Fidelity Investments’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.16M | Buy |
79,973
+12,135
| +18% | +$408K | ﹤0.01% | 2615 |
|
|
2025
Q4 | $2.91M | Buy |
67,838
+8,751
| +15% | +$330K | ﹤0.01% | 2470 |
|
|
2025
Q3 | $1.67M | Buy |
59,087
+55,694
| +1,641% | +$1.67M | ﹤0.01% | 2608 |
|
|
2025
Q2 | $63.6K | Sell |
3,393
-7,219
| -68% | -$137K | ﹤0.01% | 3786 |
|
|
2025
Q1 | $191K | Buy |
10,612
+559
| +6% | +$11.3K | ﹤0.01% | 3268 |
|
|
2024
Q4 | $169K | Sell |
10,053
-38,052
| -79% | -$730K | ﹤0.01% | 3336 |
|
|
2024
Q3 | $778K | Buy |
48,105
+26,184
| +119% | +$308K | ﹤0.01% | 2684 |
|
|
2024
Q2 | $180K | Buy |
21,921
+1,259
| +6% | +$13.2K | ﹤0.01% | 3070 |
|
|
2024
Q1 | $306K | Buy |
20,662
+185
| +0.9% | +$2.49K | ﹤0.01% | 2875 |
|
|
2023
Q4 | $297K | Buy |
20,477
+155
| +0.8% | +$1.58K | ﹤0.01% | 2831 |
|
|
2023
Q3 | $219K | Buy |
20,322
+228
| +1% | +$2.74K | ﹤0.01% | 2864 |
|
|
2023
Q2 | $259K | Sell |
20,094
-263,538
| -93% | -$3.56M | ﹤0.01% | 2869 |
|
|
2023
Q1 | $3.74M | Sell |
283,632
-605,569
| -68% | -$9.62M | ﹤0.01% | 2186 |
|
|
2022
Q4 | $13.3M | Sell |
889,201
-659,458
| -43% | -$6.05M | ﹤0.01% | 1778 |
|
|
2022
Q3 | $18.3M | Sell |
1,548,659
-864,048
| -36% | -$11.7M | ﹤0.01% | 1643 |
|
|
2022
Q2 | $27.3M | Sell |
2,412,707
-5,473
| -0.2% | -$110K | ﹤0.01% | 1531 |
|
|
2022
Q1 | $72.3M | Sell |
2,418,180
-38,979
| -2% | -$1.06M | 0.01% | 1227 |
|
|
2021
Q4 | $65.1M | Sell |
2,457,159
-97,150
| -4% | -$2.93M | ﹤0.01% | 1308 |
|
|
2021
Q3 | $92.7M | Buy |
2,554,309
+1,849
| +0.1% | +$72.8K | 0.01% | 1136 |
|
|
2021
Q2 | $111M | Buy |
2,552,460
+1,840
| +0.1% | +$69.5K | 0.01% | 1080 |
|
|
2021
Q1 | $87.2M | Buy |
2,550,620
+459,310
| +22% | +$18.2M | 0.01% | 1130 |
|
|
2020
Q4 | $73.2M | Sell |
2,091,310
-29,430
| -1% | -$852K | 0.01% | 1168 |
|
|
2020
Q3 | $50.9M | Sell |
2,120,740
-25,530
| -1% | -$627K | 0.01% | 1182 |
|
|
2020
Q2 | $39.3M | Sell |
2,146,270
-58,446
| -3% | -$1.05M | ﹤0.01% | 1267 |
|
|
2020
Q1 | $34.4M | Sell |
2,204,716
-79,390
| -3% | -$1.69M | ﹤0.01% | 1176 |
|
|
2019
Q4 | $48.9M | Sell |
2,284,106
-48,880
| -2% | -$1.01M | 0.01% | 1220 |
|
|
2019
Q3 | $43.6M | Sell |
2,332,986
-174,915
| -7% | -$3.61M | 0.01% | 1220 |
|
|
2019
Q2 | $65.5M | Buy |
2,507,901
+328
| +0% | +$7.4K | 0.01% | 1105 |
|
|
2019
Q1 | $64.4M | Buy |
2,507,573
+7,972
| +0.3% | +$182K | 0.01% | 1104 |
|
|
2018
Q4 | $57.5M | Buy |
2,499,601
+2,949
| +0.1% | +$83.2K | 0.01% | 1090 |
|
|
2018
Q3 | $80.1M | Buy |
2,496,652
+42,948
| +2% | +$1.29M | 0.01% | 1045 |
|
|
2018
Q2 | $69.4M | Buy |
2,453,704
+244,892
| +11% | +$8.71M | 0.01% | 1116 |
|
|
2018
Q1 | $78.2M | Buy |
2,208,812
+11,446
| +0.5% | +$458K | 0.01% | 1088 |
|
|
2017
Q4 | $85.3M | Buy |
2,197,366
+331,901
| +18% | +$12.6M | 0.01% | 1065 |
|
|
2017
Q3 | $47.4M | Buy |
1,865,465
+29,679
| +2% | +$722K | 0.01% | 1326 |
|
|
2017
Q2 | $50.1M | Buy |
1,835,786
+2,212
| +0.1% | +$60.5K | 0.01% | 1286 |
|
|
2017
Q1 | $60.7M | Buy |
1,833,574
+350,246
| +24% | +$8.93M | 0.01% | 1211 |
|
|
2016
Q4 | $35.3M | Buy |
1,483,328
+65,213
| +5% | +$1.87M | ﹤0.01% | 1449 |
|
|
2016
Q3 | $52M | Buy |
1,418,115
+35,949
| +3% | +$1.03M | 0.01% | 1275 |
|
|
2016
Q2 | $30.8M | Buy |
1,382,166
+23,828
| +2% | +$592K | ﹤0.01% | 1482 |
|
|
2016
Q1 | $28.3M | Buy |
1,358,338
+30,450
| +2% | +$751K | ﹤0.01% | 1502 |
|
|
2015
Q4 | $40.2M | Buy |
1,327,888
+325
| +0% | +$9.85K | 0.01% | 1346 |
|
|
2015
Q3 | $32.8M | Buy |
1,327,563
+5,406
| +0.4% | +$161K | ﹤0.01% | 1433 |
|
|
2015
Q2 | $42.4M | Buy |
1,322,157
+1,502
| +0.1% | +$57.4K | 0.01% | 1406 |
|
|
2015
Q1 | $47.1M | Buy |
1,320,655
+3,764
| +0.3% | +$103K | 0.01% | 1358 |
|
|
2014
Q4 | $29.9M | Hold |
1,316,891
| – | – | ﹤0.01% | 1566 |
|
|
2014
Q3 | $25.5M | Buy |
1,316,891
+3,921
| +0.3% | +$111K | ﹤0.01% | 1640 |
|
|
2014
Q2 | $47.7M | Buy |
1,312,970
+36
| +0% | +$1.22K | 0.01% | 1360 |
|
|
2014
Q1 | $50.9M | Buy |
1,312,934
+420,979
| +47% | +$15M | 0.01% | 1313 |
|
|
2013
Q4 | $25.4M | Sell |
891,955
-164,332
| -16% | -$4.82M | ﹤0.01% | 1608 |
|
|
2013
Q3 | $37.8M | Hold |
1,056,287
| – | – | 0.01% | 1412 |
|
|
2013
Q2 | $35.3M | Buy |
+1,056,287
| New | +$47.9M | 0.01% | 1413 |
|
Other funds holding RIGL
AC
VCM
Fidelity Investments's RIGL Position: Q1 2026 in Review
Fidelity Investments increased its Rigel Pharmaceuticals (RIGL) stake by 18% in Q1 2026, buying an estimated $408K and bringing the position to 79,973 shares worth $2.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2615.
Fidelity Investments first reported a position in RIGL in Q2 2013 and has held it in 52 quarters since. The position peaked at $111M in Q2 2021. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.
- Fidelity Investments held 79,973 shares of Rigel Pharmaceuticals worth $2.16M as of Q1 2026.
- Fidelity Investments bought 12,135 Rigel Pharmaceuticals shares in Q1 2026, an estimated $408K.
- Rigel Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2615 holding.
- Fidelity Investments first reported a position in Rigel Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Fidelity Investments's Rigel Pharmaceuticals position peaked at $111M in Q2 2021.
- 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.